Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

10.56USD
1 Aug 2013
Price Change (% chg)

$0.39 (+3.83%)
Prev Close
$10.17
Open
$10.46
Day's High
$10.68
Day's Low
$10.45
Volume
26,148
Avg. Vol
83,792
52-wk High
$10.68
52-wk Low
$3.90

RGEN.OQ

Chart for RGEN.OQ

About

Repligen Corporation is a United States-based life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. The Company manufactures Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. It also supplies... (more)

Overall

Beta: 0.87
Market Cap (Mil.): $319.77
Shares Outstanding (Mil.): 31.44
Dividend: --
Yield (%): --

Financials

  RGEN.OQ Industry Sector
P/E (TTM): 21.02 37.93 37.76
EPS (TTM): 0.48 -- --
ROI: 19.08 19.48 18.76
ROE: 19.56 20.17 19.59
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks